Get detailed information on Alogliptin and Metformin, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Get detailed information on Alogliptin and Pioglitazone, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it.

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar control.” Mary Parks, M.D., director of the Division of Metabolism and Endocrinology Products in ...

And for Takeda's alogliptin, a dipeptidyl peptidase 4 inhibitor for type 2 diabetes, the PDUFA date was extended from October 2008 to June 2009. Although big pharma may be able to bear the ...

Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

Suggested remit: To appraise the clinical and cost effectiveness of insulin icodec within its marketing authorisation for treating type 2 diabetes. Following an update from the company (Novo Nordisk), ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.